<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7262305\results\search\disease\results.xml">
  <result pre="italic;} J Am Geriatr SocJ Am Geriatr Soc10.1111/(ISSN)1532-5415JGSJournal of the" exact="American" post="Geriatrics Society0002-86141532-5415John Wiley &amp;amp; Sons, Inc.Hoboken, USA doi: 10.1111/jgs.16489JGS16489"/>
  <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
  <result pre="needing intensive care, ventilators, and other medical equipment currently in" exact="short" post="supply. Although the virus has the ability to infect"/>
  <result pre="diseases affecting primarily older adults, even diseases as disparate as" exact="cancer" post="and heart disease, have as a common (and major)"/>
  <result pre="affecting primarily older adults, even diseases as disparate as cancer" exact="and heart" post="disease, have as a common (and major) cause the"/>
  <result pre="primarily older adults, even diseases as disparate as cancer and" exact="heart" post="disease, have as a common (and major) cause the"/>
  <result pre="that often accompanies the aging process.1 This is true for" exact="chronic" post="diseases, but it is also true for acute ones"/>
  <result pre="true for chronic diseases, but it is also true for" exact="acute" post="ones such as COVIDâ€�19. Weakened resilience lowers our capacity"/>
  <result pre="our capacity to respond to the physiologic challenge of an" exact="acute" post="infection. Importantly, preclinical work is already showing that interventions"/>
  <result pre="ability of a variety of preclinical models to withstand both" exact="chronic" post="and acute challenges. Some are already being tried in"/>
  <result pre="a variety of preclinical models to withstand both chronic and" exact="acute" post="challenges. Some are already being tried in the clinic,"/>
  <result pre="immune response. As a result, when a virus or other" exact="acute" post="insult activates this already alert innate immune system, a"/>
  <result pre="inflammatory cytokines, and decreased the incidence and severity of laboratoryâ€�confirmed" exact="viral" post="respiratory tract infections including coronavirus infections. Although a recent"/>
  <result pre="cytokines, and decreased the incidence and severity of laboratoryâ€�confirmed viral" exact="respiratory" post="tract infections including coronavirus infections. Although a recent large"/>
  <result pre="decreased the incidence and severity of laboratoryâ€�confirmed viral respiratory tract" exact="infections" post="including coronavirus infections. Although a recent large phase 3"/>
  <result pre="large phase 3 trial of RTB101 failed to reach its" exact="primary" post="end point, that point was not the incidence or"/>
  <result pre="point, that point was not the incidence or severity of" exact="viral" post="respiratory tract infections. Importantly, both everolimus and RTB101 have"/>
  <result pre="that point was not the incidence or severity of viral" exact="respiratory" post="tract infections. Importantly, both everolimus and RTB101 have been"/>
  <result pre="of caution, senolytics and other geroscienceâ€�based approaches would not limit" exact="infection" post="rates. They would only protect the frail against the"/>
  <result pre="protect the frail against the more severe consequences of the" exact="disease" post="including death. Thus the geroscience approach needs to be"/>
  <result pre="is not unusual. We have been there before with severe" exact="acute" post="respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), as"/>
  <result pre="not unusual. We have been there before with severe acute" exact="respiratory" post="syndrome (SARS), Middle East respiratory syndrome (MERS), as well"/>
  <result pre="unusual. We have been there before with severe acute respiratory" exact="syndrome" post="(SARS), Middle East respiratory syndrome (MERS), as well as"/>
  <result pre="there before with severe acute respiratory syndrome (SARS), Middle East" exact="respiratory" post="syndrome (MERS), as well as the seasonal flu. In"/>
  <result pre="before with severe acute respiratory syndrome (SARS), Middle East respiratory" exact="syndrome" post="(MERS), as well as the seasonal flu. In each"/>
  <result pre="a general approach, modern medicine focuses on developing treatments against" exact="chronic" post="diseases such as cardiovascular or cancer or diabetes, to"/>
  <result pre="medicine focuses on developing treatments against chronic diseases such as" exact="cardiovascular" post="or cancer or diabetes, to try to redress damage"/>
  <result pre="on developing treatments against chronic diseases such as cardiovascular or" exact="cancer" post="or diabetes, to try to redress damage already produced,"/>
  <result pre="with multiple morbidities, in the form of more than one" exact="chronic" post="disease. And then the complications get exacerbated by the"/>
  <result pre="exacerbated by the sudden appearance of yet one more disease:" exact="acute" post="infections with SARSâ€�CoV2. In such patients, addressing any of"/>
  <result pre="by the sudden appearance of yet one more disease: acute" exact="infections" post="with SARSâ€�CoV2. In such patients, addressing any of their"/>
  <result pre="to playing a game of whackâ€�aâ€�mole. You take care of" exact="disease" post="1, only for disease 2 to become the major"/>
  <result pre="of whackâ€�aâ€�mole. You take care of disease 1, only for" exact="disease" post="2 to become the major issue. This is not"/>
  <result pre="issue. This is not the case with geroscience, which is" exact="disease" post="blind, in that it aims to improve the hostâ€™s"/>
  <result pre="immediate problem at hand is a virus attacking mainly the" exact="respiratory" post="tract, naturally the focus has been on the immune"/>
  <result pre="new model for investigating the links between aging biology and" exact="susceptibility to" post="agingâ€�related chronic diseases. Public Policy Aging Rep.2013;23:7â€�11. 2YousefzadehMJ, ZhuY,"/>
  <result pre="investigating the links between aging biology and susceptibility to agingâ€�related" exact="chronic" post="diseases. Public Policy Aging Rep.2013;23:7â€�11. 2YousefzadehMJ, ZhuY, McGowanSJ, et"/>
  <result pre="phenotypes reveal cellâ€�nonautonomous functions of oncogenic RAS and the p53" exact="tumor" post="suppressor. PLoS Biol.2008;6:2853â€�2868.19053174 5MannickJB, MorrisM, HockeyHâ€�UP, et al. TORC1"/>
  <result pre="HockeyHâ€�UP, et al. TORC1 inhibition enhances immune function and reduces" exact="infections" post="in the elderly. Science Transl Med. 2018;10(449):eaaq1564."/>
 </snippets>
</snippetsTree>
